about
Epigenetic silencing of Notch signaling in gastrointestinal cancersEicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa.Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancersChemoprevention of intestinal polyps in ApcMin/+ mice fed with western or balanced diets by drinking annurca apple polyphenol extract.Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors modelInflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells.A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib?Somatic APC mosaicism and oligogenic inheritance in genetically unsolved colorectal adenomatous polyposis patients.Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense?miR-155 is Down-regulated in Familial Adenomatous Polyposis and Modulates Wnt Signaling by Targeting AXIN1 and TCF4Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading
P50
Q27022485-CF1E5955-15B2-421A-AA85-4BE66DA05CEEQ35133949-8E56E487-2A8E-4467-B367-DC202E03C8B9Q36612486-2FAE40ED-7C6C-4209-9F8A-E48C712391B3Q36889627-FA559F3B-D399-40A5-9AD2-00E5E66FAA5CQ37223226-1DE3CB08-BA60-416C-9B60-878776C415EBQ37258214-B386D8A1-A6A6-4890-BFE1-0028383DD68BQ38364298-B9480744-A07A-4BC1-838F-EEE4686CD6F8Q38966079-DEFCC10B-77EE-44DA-9367-B5551C9FC1D3Q39897268-4EA20876-D766-470D-8424-B06BE20E8276Q41287600-6BB0503F-91BB-4BA1-A707-785174AA767CQ41954579-50831ACB-EAE5-40D3-AC11-D49401AC7113Q46802850-A2A28117-3676-41BA-9E57-93D5545065A9Q48171568-F98D17B7-5B0D-44AF-AC56-66499528E9DAQ54446563-5C637539-B0D8-46A9-BB54-5B2F295364C9Q56350148-31DF665A-8A6B-4274-9B46-BBA52AF8C1B9Q56999980-FA66F995-5A93-4917-A51A-C71167CA3A22
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giulia Piazzi
@ast
Giulia Piazzi
@en
Giulia Piazzi
@es
Giulia Piazzi
@nl
type
label
Giulia Piazzi
@ast
Giulia Piazzi
@en
Giulia Piazzi
@es
Giulia Piazzi
@nl
prefLabel
Giulia Piazzi
@ast
Giulia Piazzi
@en
Giulia Piazzi
@es
Giulia Piazzi
@nl
P106
P1153
55592708600
P21
P31
P496
0000-0002-8025-2202